Frank Holler, Director
Frank Holler is an active investor and successful entrepreneur. He previously served as President & CEO of Xenon Pharmaceuticals Inc.; President & CEO of ID Biomedical Corporation; and as a founding director of Angiotech Pharmaceuticals.

Don Enns has been actively involved in the Canadian life sciences industry for over 20 years. He was previously the President and CEO of Cantest, a life science company providing scientific expertise and consultation in environmental, biotechnology, pharmaceutical, food safety and industrial hygiene related fields.